Baudax Bio, Inc.
BXRXQ · OTC
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Market Cap | $179 | $110 | $52 | $17 |
| - Cash | $363 | $1,416 | $3,803 | $5,259 |
| + Debt | $8,097 | $8,771 | $7,433 | $7,119 |
| Enterprise Value | $7,913 | $7,465 | $3,682 | $1,877 |
| Revenue | $0 | $0 | $0 | $310 |
| % Growth | – | – | -100% | – |
| Gross Profit | $0 | $0 | $0 | -$4,482 |
| % Margin | – | – | – | -1,445.8% |
| EBITDA | -$5,409 | -$4,032 | -$4,685 | -$7,571 |
| % Margin | – | – | – | -2,442.3% |
| Net Income | -$1,934 | -$7,375 | $11,404 | -$9,250 |
| % Margin | – | – | – | -2,983.9% |
| EPS Diluted | -0.3 | -1.51 | 4.91 | -12.33 |
| % Growth | 80.1% | -130.8% | 139.8% | – |
| Operating Cash Flow | -$2,413 | -$3,446 | -$4,664 | -$3,783 |
| Capital Expenditures | -$21 | $0 | $0 | $0 |
| Free Cash Flow | -$2,434 | -$3,446 | -$4,664 | -$3,783 |